Home/ Stocks/ TXMD

TherapeuticsMD, Inc.

TXMD XNAS

$2.12 +0.01 (+0.47%) ▲ 15-min delayed

Open

$2.15

High

$2.15

Low

$2.04

Volume

13.4K

Market Cap

$24.54M

About TherapeuticsMD, Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 1 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$724.0K	$95.0K	$0.01
FY 2025	$3.02M	$-569,000	$-0.05
Q3 2025	$784.0K	$152.0K	$0.01
Q2 2025	$952.0K	$551.0K	$0.05

Earnings & Analyst Ratings

Next Earnings: Mon, Aug 10, 2026

Calendar →

Related Market News

No specific coverage for TXMD yet. Check out our latest market news or earnings calendar.

Get TXMD Alerts

Stay ahead with breaking news, price alerts, and expert analysis on TherapeuticsMD, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.